Form S-1/A Apimeds Pharmaceuticals
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250206/A92ZPQ2CLC22LZ72222P2ZY2WRBBZ2224G72
Filed on: February 6, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 20/20 BioLabs meets with East Asia partners to explore expansion
- FDA approves GSK lung cancer drug Jideytro ahead of schedule
- FDA grants priority review for Pfizer's Talzenna and Xtandi combo in prostate cancer
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
